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Abstract
Objective: Cardiac surgery with cardiopulmonary bypass (CPB) results in vascular injury and tissue damage which involves leukocyte-
endothelial interactions mediated by cytokines and adhesion molecules. This study was designed to demonstrate the effect of normothermic
and hypothermic CPB to cytokine and soluble adhesion molecule levels in adults and to determine whether these levels correlate to the
patients postoperative course. Design and patients: In 25 patients after normothermic and in 25 patients after hypothermic coronary artery
bypass grafting with cardiopulmonary bypass (CPB), blood samples for cytokine and soluble adhesion molecule analysis were taken
preoperatively, 24, 36, 48 h, and 6 days postoperatively. Soluble adhesion molecules (sE-selectin, sICAM-1) were measured by ELISA
and cytokines (TNF-a, IL-6, IL-8) by chemilumenscent-immunoassay. Clinical data were collected prospectively. Results: Postoperatively,
adhesion molecule and cytokine levels were signi®cantly elevated after CPB. Mean plasma levels of sICAM-1 was 2.4-fold higher after 6
days. Mean plasma concentration of sE-selectin peaked after 48 h with a 2-fold increase compared to normothermic conditions. In the
hypothermia group sICAM-1, sE-selectin, IL-6, and IL-8 showed signi®cantly higher levels (P , 0:0057, P , 0:0012, P , 0:0419,
P , 0:0145) after 24 h compared to the normothermia group. No clinical differences were seen. Conclusion: Adhesion molecules and
cytokines are elevated after CPB. Patients after hypothermic CPB show signi®cant higher sICAM-1, sE-selectin, IL-6, and IL-8 levels after
24 h compared to normothermic conditions. These results are mainly due to longer CPB and crossclamp times but do not alter the patient's
postoperative course. q 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Adhesion of leukocytes to endothelium and migration
into tissues are important events in the in¯ammatory
response to cardiopulmonary bypass. These leukocyte-
endothelial interactions are mediated by various adhesion
molecules on the surface of activated leukocytes, platelets
and endothelium. In addition to membrane-bound mole-
cules, soluble isoforms are found in the circulating blood.
Cardiac operations using cardiopulmonary bypass (CPB)
are associated with release of various cytokines, activation
of the coagulation cascade, and increased plasma levels of
circulating adhesion molecules [1]. An increase in soluble
adhesion molecules results either from increased expression
on activated endothelial cells or from increased proteolytic
cleavage of endothelial-bound forms secondary to endothe-
lial cell damage [2]. Thus, high levels of soluble adhesion
molecules may serve as markers for activated or damaged
endothelium. The role of endothelial selectin (E-selectin)
and intercellular adhesion molecule-1 (ICAM-1) consist of
initiating rolling and mediating ®rm adherence of leuko-
cytes to the endothelium with subsequent migration into
tissues [2].
A strategy that would inhibit the migration of leukocytes
across the endothelial layer would blunt the in¯ammatory
response induced by CPB and prevent the tissue ischemia-
reperfusion injuries. Different therapeutic methods have
been proposed by us and others including salicylates,
complement receptor or adhesion molecule blocking agents
[3,4]. Other concepts to attenuate myocardial reperfusion
injury consist of inhibiting cytokine release and/or induction
European Journal of Cardio-thoracic Surgery 17 (2000) 723±728
1010-7940/00/$ - see front matter q 2000 Elsevier Science B.V. All rights reserved.
PII: S1010-7940(00)00401-2
www.elsevier.com/locate/ejcts
* Corresponding author. Tel.: 141-1-255-3801; fax: 141-1-255-4369.
E-mail address: gregor.zund@chi.usz.ch (G. ZuÈnd).
of adhesion molecule expression by establishing hypother-
mic conditions during CPB or removing circulating cyto-
kines by instituting modi®ed ultra®ltration [5].
This study was designed to demonstrate the effect of
normothermic and hypothermic CPB to soluble adhesion
molecule levels in adults and to determine whether these
levels correlate to the patients postoperative course.
2. Methods
2.1. Patient groups
Patients recruited for this prospectively controlled, rando-
mized study were undergoing elective coronary artery
bypass grafting using normothermic or hypothermic cardi-
opulmonary bypass. Between July 1997 and December
1998 we enrolled 25 patients (mean age 58.5 years) in the
normothermia and 25 patients (mean age 55.9 years) in the
hypothermia group. Informed consent was obtained from
each patient according to the protocol of the ethics commit-
tee of the hospital.
2.2. Operative techniques
Cardiopulmonary bypass was performed with a StoÈckert
roller pump system (StoÈckert Instrumente GmbH, Munich,
Germany) and a Shiley-Dideco Maxima hollow ®ber oxyge-
nator (Dideco, Mirandola, Italy). Myocardial protection was
accomplished using cold cristalloid cardioplegia with an
initial dose of 30 ml/kg repeated every 20 min. Before aortic
declamping, 15 ml/kg warm blood cardioplegia (`hot shot')
was administered. The operations were performed under
normothermic (348C) by only one surgeon and under
hypothermic conditions (24±268C) by three different
surgeons according to the usual practice of our clinic.
Rewarming was achieved using the heat-exchange oxyge-
nator, warming blanket, and heated humidi®ed gases to
reach a rectal temperature of .348C before terminating
CPB. The use of intra- and postoperatively medications
did not differ between the two groups.
2.3. Blood sampling and analysis
Blood samples (10 ml) for measuring cytokines, soluble
E-selectin (sE-selectin), soluble ICAM-1 (sICAM-1), inter-
leukin-6 (IL-6), interleukin-8 (IL-8), and tumour necrosis
factor-a (TNF-a) were obtained from a venous line of the
patient at the following times: at induction of anesthesia, 24,
36 (only sE-selectin and sICAM-1), 48 h and 6 days after
CPB. Blood samples were allowed to coagulate, centrifuged
for 20 min at 48C and the serum was aliquoted and stored at
2708C [2]. Soluble adhesion molecules in the serum were
measured using commercially available ELISA kits (R&D
Systems, Abingdon, UK). Standards of known concentra-
tion were run in parallel together with a control serum. The
optical density (OD) was read at 450 nm with a correction
wavelength set to 630 nm. The absorbance was plotted
against a standard curve of known concentrations and
expressed as ng/ml. The values were corrected by hemodi-
lution using hematocrit. Cytokines (TNF-a, IL-6, IL-8)
were analyzed by the technique of a solid-phase, two-site
chemilumenscent enzyme immunometric assay (Immulite,
EURO/DPC Ltd, Gwynedd, UK).
2.4. Clinical variables
Patient demographic data and medical history were
collected prospectively, as well as the postoperative course
including intubation time, blood loss, ICU stay, occurrence
of atrial ®brillation or pulmonary infection requiring anti-
biotic treatment and length of hospital stay.
2.5. Statistics
Data were processed with Statview software (Abacus
Concepts Inc., Berkeley, CA). All data were expressed as
mean with one standard deviation and were graphically
presented as bar charts. Intergroup comparison was
performed with the Mann±Whitney test for unpaired data.
Intragroup comparison was done using the Wilcoxon test for
paired data. Normally distributed values between groups
were compared by the student's t-test or in case of repeated
measurements over the time by analysis of variance
(ANOVA) for repeated measures. Non-normally distributed
data were compared either with the Fisher's exact test or the
Mann±Whitney U-test with Bonferroni correction.
3. Results
In all patients sICAM-1 and sE-selectin were signi®cantly
elevated after CPB. The mean plasma level of sICAM-1
increased up to 2.4-fold (635 ng/ml) after 6 days compared
to the preoperative sample (262 ng/ml). Mean plasma
concentrations for sE-selectin showed a peak after 48 h of
75 ng/ml with a slight regression after 6 days representing
an increase of at least 2-fold compared to the control sample
(45 ng/ml). The time course of plasma level of soluble adhe-
sion molecules differed between normothermic and
hypothermic CPB demonstrating signi®cantly higher
sICAM-1 (P  0:0057, P  0:0049) and sE-selectin
(P  0:0012, P  0:015) levels in hypothermia compared
to normothermic conditions after 24 and 36 h. However,
there were no differences seen in sICAM-1 and sE-selectin
expression 6 days after the operation between normothermia
and hypothermia although signi®cantly higher than the
preoperative values (Fig. 1). In line with the adhesion mole-
cules cytokine levels (IL-6, P  0:0419, IL-8 P  0:0145)
were signi®cantly higher in the hypothermia group at 24 h
postoperatively (Fig. 2).
Regarding the demographic data the two groups were not
signi®cantly different for age and gender although men and
women were unevenly distributed. There were more men
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undergoing coronary artery bypass than women (38 men vs.
12 women). However, the only difference in the operative
variables between the two groups was the mean total cardi-
opulmonary bypass and the mean crossclamp time which
were signi®cantly shorter in the normothermia group (74
min/37 min) compared to the hypothermia group (101
min/62 min). This discrepancy was mainly due to the
surgeon's experience in the hypothermia group.
The postoperative course in both groups showed no
signi®cant difference in intubation time, infection rate,
length of ICU or hospital stay (Table 1). Postoperative atrial
®brillation was more frequent in normothermia compared to
hypothermia (9 vs. 3 patients, NS). Blood loss was similar in
both groups. Age, gender and pump or crossclamp time
showed no correlation to adhesion molecule or cytokine
levels.
4. Discussion
Plasma levels of soluble adhesion molecules sICAM-1
and sE-selectin, as well as IL-6 and IL-8 are signi®cantly
higher in hypothermic cardiopulmonary bypass compared to
normothermic conditions. An increase in soluble adhesion
molecules results either from increased expression in acti-
vated endothelial cells or from increased proteolytic clea-
vage of endothelial-bound forms secondary to endothelial
cell injury [6]. Increased serum levels of sE-selectin and
sICAM-1 not only may serve as markers for the degree of
vascular cell injury, but also retain its ability to bind to
CD11b/CD18 and may compete with the membrane-
bound ICAM-1 for leukocyte adhesion, thus preventing
neutrophil-induced tissue damage [7]. The increased
expression of myocardial ICAM-1 and E-selectin has been
demonstrated in several studies [8], as well as the role of
early ICAM-1 induction in neutrophil-mediated myocardial
damage after cardiopulmonary bypass [9,10]. In vitro
studies revealed induction of E-selectin and ICAM-1
mRNA in human umbilical vein endothelial cells by IL-1
and TNF-a within 1±4 h [11]. In addition isolated canine
myocardium have been shown to express ICAM-1 on stimu-
lation either with cytokines or with postreperfusion cardiac
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Fig. 2. Expression of cytokines after normothermic and hypothermic cardi-
opulmonary bypass (CPB) at different time intervals (*P , 0:05), values
are mean ^ standard deviation.
Fig. 1. Expression of sICAM-1 and sE-selectin after normothermic and hypothermic cardiopulmonary bypass (CPB) at different time intervals (*P , 0:05,
**P , 0:01), values are mean ^ standard deviation.
lymph. All these observations suggest that ICAM-1 induc-
tion might occur in atrial myocytes, as well as in vascular
endothelium following ischemia and reperfusion [8].
Cardiopulmonary bypass is associated with increased
plasma levels of circulating adhesion [12]. However, no
upregulation of those molecules could be found in major
non-cardiac operation compared to patients undergoing
elective coronary artery bypass grafting [13]. E-selectin is
particularly interesting because it is found only on activated
endothelium, in contrast to other adhesion molecules which
have a wider tissue distribution. The detection of soluble E-
selectin in the blood has therefore to be taken as conclusive
evidence of endothelial cell activation.
In the present study, the time course observed for adhe-
sion molecule expression after CPB showed a characteristic
pattern with a rapid and sustained increase of sE-selectin
and sICAM-1 levels after surgery. As expected from prior
own in vitro studies E-selectin had a slightly earlier peak
level at 48 h in normothermia followed by an immediate
decline but without normalization to baseline levels after 6
postoperative days [14]. In contrast, ICAM-1 increased
constantly showing highest levels 6 days postoperatively.
Under hypothermic conditions however, changes in
ICAM-1 and E-selectin levels were markedly different
from those under normothermic conditions. Both molecules
showed signi®cantly higher levels at 24 and 36 h after CPB
compared to normothermic conditions approximating after
6 days. The persistent high plasma levels of adhesion mole-
cules for at least 6 postoperative days in adult patients after
cardiopulmonary bypass are striking and may generally be
explained by continuous induction of cytokines throughout
the whole hospital stay until discharge.
Three different factors may possibly be responsible for
higher adhesion molecule and cytokine production after
hypothermic cardiopulmonary bypass: cardiopulmonary
bypass time, ischemia time and bypass temperature.
According to the known facts of cytokine biology, the
immediate early effects of CPB is the activation of comple-
ment factors, such as C3a and C5a, which alone or with
other factors result in induction of adhesion molecules.
We believe that a continuous stimulus does lead to higher
cytokine levels, and therefore do consider longer cardiopul-
monary bypass time the most important factor for those
signi®cantly higher adhesion molecule and cytokine levels.
The same mechanism probably may not be applied for
longer ischemia time. Based on our previous laboratory
results with human endothelial cell we found that ischemia
alone simulated in a hypoxic chamber does not lead to
signi®cantly higher induction of adhesion molecules
compared to normoxia. However, adding TNF-a to the
medium mimicking bypass conditions does serve as a potent
trigger with consecutive major adhesion molecule upregula-
tion [15]. As we showed in a previous study the complement
component C5a and TNF-a have a synergistic effect on the
induction of endothelial E-selectin and ICAM-1 expression
which clearly is dose-dependent [16]. These results indicate
that ischemia itself without the presence of cytokines may
only to a certain extent be responsible for excessive adhe-
sion molecule expression. Certainly, those two factors are
time-dependent and therefore directly correlated to the
surgeon's technical experience.
The temperature during cardiopulmonary bypass proce-
dures is still a subject of ongoing debate [17] although
moderate hypothermic or even normothermic cardiopul-
monary bypass in cardiac surgery has gained more and
more acceptance in recent years. However, the extent of
adhesion molecule or cytokine upregulation under
normothermic and hypothermic conditions has always
been controversial [18]. Boldt and coworkers reported of a
study in which no signi®cant differences in adhesion mole-
cule expression except for P-selectin was found between
normothermia and hypothermia in patients undergoing
coronary artery bypass grafting in a matched patient popu-
lation [19]. The reasons for the higher sP-selectin levels
under hypothermic conditions could only be speculated on
that an increase either results from the in¯ammatory process
itself or from changes of intravascular coagulation, i.e.
alterations in platelet function and thrombin generation
[19]. Interestingly, it has also been reported that secretion
of high levels of sP-selectin appear to prevent the adhesion
process of neutrophils via CD11b to endothelium by block-
ing the TNF-mediated activation of the b2-integrin complex
[10]. From a cardiac surgical standpoint hypothermia to
reduce myocardial oxygen demand has been standard prac-
tice for years. Lichtenstein et al. reassessed the need for
hypothermia in cardiac surgery and highlighted its adverse
effects [20]. It has been demonstrated that the decrease in
oxygen demand from the working to the arrested heart is
mainly due to elimination of electromechanical activity,
rather than cooling. Hypothermic arrested hearts require
only about 5% less oxygen than arrested and normothermic
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Table 1
Clinical variables in normothermic and hypothermic bypass patientsa
Normothermic CPB Hypothermic CPB P-value
Age (years) 60.8 ^ 8.9 56.7 ^ 12.4 NS
Gender (female/
male)
4/21 8/17 NS
Bypass time (min) 74 ^ 22 101 ^ 33 0.0012
Crossclamp time
(min)
37 ^ 8 63 ^ 27 0.0002
Intubation (days) 1 2.1 ^ 4.8 NS
ICU (days) 2.2 ^ 3.4 3.6 ^ 5.8 NS
Pulmonary
infection
(patients)
4 9 NS
Atrial ®brillation
(patients)
9 3 NS
Blood loss (units) 1.3 ^ 0.3 1.8 ^ 0.7 NS
Hospital stay
(days)
10.9 ^ 4.4 13.7 ^ 8.2 NS
a CPB, cardiopulmonary bypass; NS, not signi®cant; values are mean ^
standard deviation.
hearts. In contrast, the difference of oxygen consumption
between an arrested and working state exceeds 95% so
that the need for hypothermia becomes questionable [20].
It is known that hypothermia changes the activity of impor-
tant enzymes, membrane stability and adenosine tripho-
sphate generation and utilization which might lead to
disturbed cellular function in in vivo conditions [21].
Even changes in ultrastructure and cellular edema were
reported leading to cellular necrosis after hypothermia and
rewarming [22,23]. Supported by a study of Frering et al. in
which no systemic release of TNF-a and IL-1 was found in
normothermic CPB [24], we believe that those changes seen
in hypothermic CPB may be due to cell damage by the
cooling and rewarming process and is re¯ected with exces-
sive cytokine production and subsequent adhesion molecule
expression. Unfortunately, we do not have any data to
con®rm this hypothesis.
The pathophysiology of these responses to cardiopulmon-
ary bypass are gradually becoming clari®ed. Approaches
can be described to prevent or at least modify this in¯am-
matory cascade based on the understanding of the whole
mechanism. Administration of scavenging agents could be
used to reduce the activation and release of the free radical
response to CPB [25]. Other studies have been undertaken
to demonstrate the ef®cacy of a modi®ed ultra®ltration in
removing in¯ammatory mediators generated during CPB
[5]. Even more promising might be new drugs to prevent
complement activation and cytokine generation to combat
in¯ammation and bleeding complications. The bene®ts of
an eventual use of anti-adhesion molecule or anti-comple-
ment receptor therapy in a clinical setting may, however, be
potentially dangerous, because altering the immunological
response by modifying the function of adhesion molecule or
the complement cascade may attenuate the injury caused by
host defense cells. Our results of still elevated adhesion
molecule levels after 6 days imply that any therapeutic treat-
ment should be performed for at least this time period until
patient discharge.
This study was conducted in a randomized patient popu-
lation undergoing elective coronary artery bypass grafting
without emergency operations and several study limitation
have to be noted. First, assessing the diagnostic or physio-
logical signi®cance of in vivo plasma levels may be dif®cult
due to discrepancy between average levels in the blood and
more accurate levels in the reperfused organ, i.e. myocar-
dium, brain [2]. High levels may also re¯ect the rate of
cellular adhesion molecule synthesis and subsequent surface
expression, the rate of cleavage from the cell surface, or
simply decreased clearance. Second, since we only recorded
postoperative clinical parameters for maximal 12 days we
cannot rule out that those higher in¯ammatory mediators do
not have any long term detrimental effects, i.e. for the
endothelium in vein grafts.
The higher plasma levels of adhesion molecules and cyto-
kines in hypothermia is only explained by longer pump or
crossclamp times and possibly due to the cooling and
rewarming process itself. Since no signi®cant clinical
changes were seen between normothermic and hypothermic
CPB we believe that intermittently higher adhesion mole-
cule and cytokine levels do not alter the patients immediate
postoperative course.
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